Reshma Kewalramani Age, Wiki and Bio

Reshma Kewalramani

Quick Info

ProfessionPresident & CEO of Vertex Pharmaceuticals
NationalityIndian
Date of BirthXX/XX/1973
AgeUnknown
BirthplaceMumbai, Maharashtra, India

Bio/Wiki

ProfessionPresident and CEO of Vertex Pharmaceuticals
Known ForBeing the first female CEO of a large US biotech company

Physical Stats & More

Eye ColorBrown
Hair ColorBrown

Educational Qualification(s)

College/University
  • Boston University (1990-1998)
  • Harvard Business School (2015)
Degrees
  • Doctor of Medicine (MD), Seven-year Liberal Arts/Medical Education Program from Boston University School of Medicine
  • General Management Program from Harvard Business School

Personal Life

Marital StatusMarried
HometownHuntington, New York, United States

Relationships & More

Children
Sons2 (twins)
DaughtersNone

Career

SummaryBeginning her career in medicine, Reshma Kewalramani transitioned into significant roles within the pharmaceutical industry. She served on the boards of prestigious organizations like the Boston University School of Medicine and Massachusetts General Hospital. Reshma's accolades include Harvard Medical School Excellence in Teaching Award and recognition in the Fortune Most Powerful Women List. Her tenure at Vertex Pharmaceuticals, where she progressed from Senior Vice President to CEO and President, marked significant advancements in the treatment of cystic fibrosis and pain management.

Some Lesser Known Facts

Reshma moved to the United States from Mumbai with her family at the age of 11.
She worked as a Resident Physician at Massachusetts General Hospital from 1998 to 2001.
Reshma was a Nephrology Fellow at Partners HealthCare from 2001 to 2002.
Her roles in the field include working as a Nephrologist and Research Fellow at Brigham and Women’s Hospital.
Reshma spent over six years at Amgen, engaging in various positions in Global Clinical Development and Medical Affairs.
She rose to Vice President and Head of the Nephrology and Metabolic Therapeutic Area at Amgen.
In 2025, she achieved FDA approval for Journavx, a groundbreaking pain medication.
An animal enthusiast, Reshma has a pet dog named Snickers.
She actively participates in philanthropy through Vertex Volunteers, supporting global nonprofit work.